Back to search

Belgium· BE-AMP-SAM166643-00

Lysox Junior 100 mg

A acetylcysteine product containing acetylcysteine, registered in Belgium by Menarini Benelux. The same ATC class is registered in 15 of our 19 countries.

ATC R05CB01

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedLysox Junior 100 mgATCR05CB01REGISTER NO.BE-AMP-SAM166643-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Acetylcysteine is registered in 15 of 19 countries.

Countries holding a registration under ATC R05CB01 (acetylcysteine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 8 of them publish a price we can compare per daily dose

Acetylcysteine · ATC R05CB01

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acetylcysteine costs, country by country.

Normalised to the WHO defined daily dose (0.5 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Acetylcysteine · price per daily dose (0.5 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.47
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Acetylcysteine
Manufacturer
Menarini Benelux
Country
Belgium (BE)
ATC code
R05CB01
ATC class
Acetylcysteine
Defined daily dose
0.5 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    1300037

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

314 interactions on record for acetylcysteine.

Graded by severity as the source publishes them — 5 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Acetylcysteine · interactions on record

314 records

  • 5 moderate
  • 2 minor
  • 307 info

Most severe, free to view

  • Insulin (human)A10AB01moderate
  • Insulin (human)A10AC01moderate
  • Insulin (human)A10AD01moderate
  • Insulin (human)A10AE01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Acetylcysteine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acetylcysteine products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Acetylcystein Hexal, Aeromuc
  • Bulgaria · Aцц, Ацетилцистеин Ромфарм
  • Cyprus · Solmucol, Trebon-N
  • Czechia · Acc, Acc Neo
  • Germany · Acc, Acc Akut Hustenlöser
  • Denmark · Acetylcystein Pharmexon, Acetylcystein Sad
  • Estonia · Acc, Acc Long
  • Spain · Acetilcisteína Alter, Acetilcisteina Aristo
  • Finland · Acetylcysteine Macure, Bisolaclar
  • France · Acetylcysteine Alpex Adultes, Acetylcysteine Arrow
  • United Kingdom (Northern Ireland) · Acepiro, Acetylcysteine Aurum Pharmaceuticals
  • Greece · Fluimucil, Lilovon
  • Croatia · Fluimukan, Fluimukan Akut
  • Hungary · Acc, Acc Hot
  • Ireland · Acetylcysteine Essential-Healthcare Ascot Laboratories (Ireland) Limited, Nacsys
  • Iceland · Mucolysin, Mucomyst
  • Italy · Acc, Acc Fluidificante E Antidoto
  • Lithuania · Acc, Acc Long
  • Luxembourg · Acetylcysteine Eg, Exomuc
  • Latvia · Acc, Acc Hot
  • Malta · Fluimucil, Trebon-N Pd.Or.Sus
  • Netherlands · Acetylcysteïhe Sanias, Acetylcysteïne Alpex
  • Norway · Acetylcystein Sandoz, Acetylcysteine Macure
  • Poland · Acc, Acc Classic
  • Portugal · Acetilcisteína Alter, Acetilcisteina Azevedos
  • Romania · Acc, Acc Cu Aroma De Mure
  • Sweden · Acetylcystein 1a Farma, Acetylcystein Alternova
  • Slovenia · Acibel, Fluimukan
  • Slovakia · Acc, Acc Long

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d94a5d0c-48cf-4d9a-8c60-2c8c7986c370
GET /v1/drugs/d94a5d0c-48cf-4d9a-8c60-2c8c7986c370?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Granules for oral solution",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Lysox Junior 100 mg",
  "name_fr": "Lysox Junior 100 mg",
  "name_nl": "Lysox Junior 100 mg",
  "amp_code": "SAM166643-00",
  "strengths": [
    "100.0000",
    "100.0000",
    "15.0000",
    "1266.8570"
  ],
  "pack_count": 1,
  "substances": [
    "Acetylcysteine",
    "Saccharin Sodium",
    "Xylitol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Acetylcysteine",
  "authorisation_numbers": [
    "BE166643"
  ]
}

See everything about acetylcysteine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.